Stay updated on Pembrolizumab in Neoplasms Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neoplasms Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed. This reflects a backend release update and does not alter the visible study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:42:16.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page’s site/application revision indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or release update rather than any change to the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:07.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:28.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0. No visible changes to the study details, eligibility criteria, or other study content.
    Difference
    0.1%
    Check dated 2026-03-19T04:55:41.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.3 now shown, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:57.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Minor metadata updates were made, including a revision tag (v3.4.2) and update dates (2026-02-10, 2026-01-29, 2026-01). The government funding lapse notice was removed.
    Difference
    0.6%
    Check dated 2026-02-11T14:30:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neoplasms Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neoplasms Clinical Trial page.